OTCMKTS:ANEB

Anebulo Pharmaceuticals (ANEB) Stock Price, News & Analysis

Anebulo Pharmaceuticals logo
$0.28 0.00 (0.00%)
As of 11/18/2026 09:37 AM Eastern

About Anebulo Pharmaceuticals Stock (OTCMKTS:ANEB)

Advanced

Key Stats

Today's Range
$0.28
▼
$0.28
50-Day Range
$0.00
▼
$0.36
52-Week Range
$0.00
▼
$2.49
Volume
100 shs
Average Volume
1,039 shs
Market Capitalization
$11.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Anebulo Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for acute cannabinoid intoxication and related medical emergencies. The company’s work is aimed at addressing the effects of cannabis and synthetic cannabinoids, including situations in which patients require urgent medical care.

Anebulo’s lead investigational product, ANEB-001, is an orally administered antagonist of the cannabinoid type 1 (CB1) receptor. The company is developing ANEB-001 to rapidly reverse the effects of cannabinoid intoxication, with potential applications in emergency and acute-care settings. The product remains investigational and has not been approved for commercial use.

Based in Austin, Texas, Anebulo conducts its development activities through clinical research and pharmaceutical collaborations. The company was established to pursue therapies for acute cannabinoid-related conditions and is led by Chief Executive Officer Simon Allen.

AI Generated. May Contain Errors.

Anebulo Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
0th Percentile Overall Score

ANEB MarketRank™: 
0.016413623305 of 5 stars

Anebulo Pharmaceuticals scored higher than 0% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Anebulo Pharmaceuticals.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Anebulo Pharmaceuticals is -1.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Anebulo Pharmaceuticals is -1.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Anebulo Pharmaceuticals has a P/B Ratio of 1.00. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    4.94% of the float of Anebulo Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Anebulo Pharmaceuticals has a short interest ratio ("days to cover") of 999.99, which indicates bearish sentiment.
  • Change versus previous month

  • Dividend Yield

    Anebulo Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    Anebulo Pharmaceuticals does not have a long track record of dividend growth.

  • News Coverage This Week

    MarketBeat has tracked 1 news article for Anebulo Pharmaceuticals this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Anebulo Pharmaceuticals insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    80.60% of the stock of Anebulo Pharmaceuticals is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    28.40% of the stock of Anebulo Pharmaceuticals is held by institutions.

  • Read more about Anebulo Pharmaceuticals' insider trading history.
Receive ANEB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Anebulo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ANEB Stock News Headlines

Anebulo Pharmaceuticals (ANEB) Expected to Announce Earnings on Wednesday
Top Trader Reveals Stunning Black Friday Deal
Others paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Trading's Thomas Wood calls it one of the firm's most powerful proprietary trading indicators, and says the company has never run a deal like this before. There are no strings attached, just a steep Black Friday discount on a tool built for traders.tc pixel
See More Headlines

ANEB Stock Analysis - Frequently Asked Questions

Anebulo Pharmaceuticals' stock was trading at $1.01 at the start of the year. Since then, ANEB shares have decreased by 72.3% and is now trading at $0.28.

Anebulo Pharmaceuticals, Inc. (OTCMKTS:ANEB) posted its quarterly earnings data on Monday, September, 29th. The company reported ($0.05) EPS for the quarter, meeting analysts' consensus estimates of ($0.05).

Shares of ANEB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
11/19/2026
Fiscal Year End
6/30/2027

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
OTCMKTS:ANEB
Previous Symbol
NASDAQ:ANEB
CIK
1815974
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.28 per share
Price / Book
1.00

Miscellaneous

Outstanding Shares
40,785,000
Free Float
7,912,000
Market Cap
$11.42 million
Optionable
Not Optionable
Beta
-1.90
7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

This page (OTCMKTS:ANEB) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners